Skip to main content
TipRanks
Go Ultimate75% OFF

Oryzon Genomics SA (ORYZF) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

ORYZF Analyst Ratings

Moderate Buy
1Ratings
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to Oryzon Genomics SA in the past 3 months

ORYZF Stock 12 Month Forecast

$10.00▲(263.64% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Oryzon Genomics SA in the last 3 months. The average price target is $10.00 with a high forecast of $10.00 and a low forecast of $10.00. The average price target represents a 263.64% change from the last price of $2.75.
Highest Price Target$10.00Average Price Target$10.00Lowest Price Target$10.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for ORYZF
Price TargetArticle
Maxim Group$10buy263.64%UpsideReiterated11/10/26
Roth MKM Analyst forecast on ORYZFUnknown AnalystNot RankedRoth MKM$13.32buy384.21%UpsideReiterated07/28/26
Jefferies Analyst forecast on ORYZFUnknown AnalystNot RankedJefferies$4.66buy69.47%UpsideReiterated05/25/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
DFTXDefinium Therapeutics
RDNTRadnet
AXGNAxoGen
PLSEPulse Biosciences
AHCOAdaptHealth

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Oryzon Genomics SA

3 Months
Jason McCarthy
Jason McCarthyMaxim Group
Success Rate1/4 ratings generated profit
25%
Average Return
-5.75%

Copying Jason McCarthy's trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -5.75% per trade.

1 Year
Jason McCarthy
Jason McCarthyMaxim Group
Success Rate0/4 ratings generated profit
0%
Average Return
-14.80%

Copying Jason McCarthy's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -14.80% per trade.

2 Years
Jason McCarthy
Jason McCarthyMaxim Group
Success Rate0/4 ratings generated profit
0%
Average Return
-14.80%

Copying Jason McCarthy's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -14.80% per trade.

ORYZF Analyst Recommendation Trends

02468Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for ORYZF
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy43201
Buy10000
Hold00000
Sell00000
Strong Sell00000
total53201

In the current month, ORYZF has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. ORYZF average Analyst price target in the past 3 months is 10.00.

ORYZF Financial Forecast

$-2$-1.25$-0.5$0.25$1Q1 2026Q3 2026Q4 2026
High$-0.05
Consensus$-0.05
Low$-0.05

ORYZF Earnings Forecast

Next quarter’s earnings estimate for ORYZF is -$0.05 with a range of -$0.05 to -$0.05. The previous quarter’s EPS was -$0.02. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

$-1$-0.5$0$0.5$1Q1 2026Q3 2026Q4 2026
High$0.00
Consensus$0.00
Low$0.00

ORYZF Sales Forecast

Next quarter’s sales forecast for ORYZF is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

ORYZF Stock Forecast FAQ

What is ORYZF’s average 12-month price target, according to analysts?
Based on analyst ratings, Oryzon Genomics SA’s 12-month average price target is $10.00.
What is ORYZF’s upside potential, based on the analysts’ average price target?
Oryzon Genomics SA has 263.64% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ORYZF a Buy, Sell or Hold?
Oryzon Genomics SA has a consensus rating of Moderate Buy which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Oryzon Genomics SA’s price target?
The average price target for Oryzon Genomics SA is $10.00. This is based on 1 12-month price targets, issued in the past 3 months. The highest analyst price target is $10.00, the lowest forecast is $10.00. The average price target represents a 263.64% increase from the current price of $2.75.
What do analysts say about Oryzon Genomics SA?
Oryzon Genomics SA’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of ORYZF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.